Syndax to Announce Fourth Quarter and Year-end 2023 Financial Results and Host Conference Call and Webcast on February 27, 2024

Rhea-AI Summary

Syndax Pharmaceuticals (SNDX) will report its Q4 and year-end 2023 financial results and provide a business update on February 27, 2024. A conference call and webcast will be held to discuss the financial results and business developments.

WALTHAM, Mass., Feb. 20, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its fourth quarter and year-end 2023 financial results and provide a business update on Tuesday, February 27, after the close of the U.S. financial markets.

In connection with the earnings release, Syndax's management will host a conference call and live audio webcast at 4:30 p.m. ET on Tuesday, February 27, 2024 to discuss the Company's financial results and provide a business update.

The live audio webcast and accompanying slides may be accessed through the Events & Presentations page in the Investors section of the Company's website. Alternatively, the conference call may be accessed through the following:

Conference ID: Syndax4Q23
Domestic Dial-in Number: 800-590-8290
International Dial-in Number: 240-690-8800
Live webcast: https://www.veracast.com/webcasts/syndax/events/SNDX4Q23.cfm

For those unable to participate in the conference call or webcast, a replay will be available on the Investors section of the Company's website at www.syndax.com approximately 24 hours after the conference call and will be available for 90 days following the call.

About Syndax

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the menin–KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. For more information, please visit www.syndax.com or follow the Company on Twitter and LinkedIn.

Syndax Contact

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

View original content:https://www.prnewswire.com/news-releases/syndax-to-announce-fourth-quarter-and-year-end-2023-financial-results-and-host-conference-call-and-webcast-on-february-27-2024-302066595.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

When will Syndax Pharmaceuticals report its Q4 and year-end 2023 financial results?

Syndax Pharmaceuticals will report its Q4 and year-end 2023 financial results on February 27, 2024.

How can I access the live audio webcast of Syndax Pharmaceuticals' conference call?

The live audio webcast can be accessed through the Events & Presentations page in the Investors section of Syndax Pharmaceuticals' website.

What are the dial-in numbers for Syndax Pharmaceuticals' conference call?

The domestic dial-in number is 800-590-8290 and the international dial-in number is 240-690-8800.

Where can I find the replay of Syndax Pharmaceuticals' conference call?

The replay will be available on the Investors section of Syndax Pharmaceuticals' website at www.syndax.com approximately 24 hours after the conference call and will be available for 90 days.

What is the ticker symbol for Syndax Pharmaceuticals?

The ticker symbol for Syndax Pharmaceuticals is SNDX.